Chronic Pulmonary Aspergillosis: Genomic Variant Analysis and Protein Dysfunction Susceptibility in a Brazilian Cohort
Authors:
- Rafaela da Silva Mendes¹RMRafaela da Silva Mendes¹
- Beatriz Martins WolffBWBeatriz Martins Wolff
- Mariana Ribeiro Costa-SiemannMCMariana Ribeiro Costa-Siemann
- Yanca Gasparini OliveiraYOYanca Gasparini Oliveira
- Gleyson Francisco da Silva CarvalhoGCGleyson Francisco da Silva Carvalho
- Lucas Liro VieiraLVLucas Liro Vieira
- Eder Alencar MouraEMEder Alencar Moura
- Karina Marinho NascimentoKNKarina Marinho Nascimento
- Lissandro Sousa RolimLRLissandro Sousa Rolim
- Andre Nathan CostaACAndre Nathan Costa
- Marcello Mihailenko Chaves MagriMMMarcello Mihailenko Chaves Magri
- Vítor Falcão de OliveiraVOVítor Falcão de Oliveira
Preprint
- 21 April 2025
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Chronic pulmonary aspergillosis (CPA) is a debilitating condition often affecting immunocompetent patients with underlying structural lung diseases, particularly pulmonary tuberculosis. This study investigates single nucleotide variants (SNVs) in immunogenetic-related genes among a Brazilian cohort with CPA. Twelve patients with confirmed CPA, based on ESCMID/ERS criteria, were sequenced using NGS technology. Variants were annotated, classified using ACMG guidelines, and analyzed for potential impact on protein interactions and immune pathways. A set of SNVs in CX3CR1, IL12B, IL4R, PTX3, CCR5 and IFNG genes were classified as variants of uncertain significance (VUS), but protein–protein interaction analysis suggests a potential role in immune evasion and dysfunction. This is the first study to apply a custom multigenic panel for CPA susceptibility in a Brazilian cohort, contributing to future functional and clinical studies in fungal immunogenetics.Keywords
All Related Versions
This publication has 12 references indexed in Scilit:
- Mortality in chronic pulmonary aspergillosis: a systematic review and individual patient data meta-analysisThe Lancet Infectious Diseases, 2024
- A new method for multiancestry polygenic prediction improves performance across diverse populationsNature Genetics, 2023
- Challenges, Characteristics, and Outcomes of Chronic Pulmonary Aspergillosis: A 11-Year Experience in A Middle-Income CountryMycopathologia, 2022
- Impact of treatment duration on recurrence of chronic pulmonary aspergillosisJournal of Infection, 2021
- Pentraxin-3 polymorphisms and pulmonary fungal disease in non-neutropenic patientsAnnals of Translational Medicine, 2020
- From genomic variation to protein aberration: Mutational analysis of single nucleotide polymorphism present in ULBP6 gene and implication in immune responseComputers in Biology and Medicine, 2019
- Pulmonary and sinus fungal diseases in non-immunocompromised patientsThe Lancet Infectious Diseases, 2017
- Pentraxin 3 Gene Polymorphisms and Pulmonary Aspergillosis in Chronic Obstructive Pulmonary Disease PatientsClinical Infectious Diseases, 2017
- Polymorphisms in Host Immunity-Modulating Genes and Risk of Invasive Aspergillosis: Results from the AspBIOmics ConsortiumInfection and Immunity, 2016
- Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and managementEuropean Respiratory Journal, 2015